China's high-quality development: A Merck China perspective - CGTN

Direct Source Verification: This story is aggregated from CGTN (cgtn.com). Full reporting rights and copyright belong to the primary publisher.
By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

Editor's Note: As Shanghai hosts the 9th China International Import Expo (CIIE) from November 5 to 10, what opportunities will China's evolving market offer to multinational companies? As China enters a new phase of high-quality development, how are global companies positioning themselves for the opportunities ahead? On The Hub, Wang Guan speaks with Rogier Janssens, president of Merck China and managing director of Merck Life Science China. He looks at Merck's long-term investment strategy in China, its engagement with the country's innovation ecosystem, and the growing role of AI in biotechnology and cancer treatment.

Original Source
https://news.cgtn.com/news/2026-11-04/China-s-high-quality-development-A-Merck-China-perspective-1RLJPCHwnLi/p.html
Visit CGTN ↗
SHARE STORY:
𝕏 f in

Related Coverage in Environment